Skip to main content

Month: July 2020

Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update

STOUGHTON, Mass., July 21, 2020 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August 5, 2020 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update.Conference Call Information: To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Q2 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.About Collegium Pharmaceutical, Inc.Collegium is a specialty pharmaceutical company committed to being the leader in responsible...

Continue reading

Golden Tag Provides Update On Strategic Growth Opportunities

TORONTO, July 21, 2020 (GLOBE NEWSWIRE) — Golden Tag Resources Ltd. (“Golden Tag” or the “Company“) (TSX.V: GOG) is pleased provide an update on the Company’s strategic opportunities and plans for growth. As silver prices continue to rebound, the Company’s 100% owned San Diego Project is well positioned as one of the largest undeveloped silver projects in Mexico, with significant potential for resource expansion.Key Highlights:The San Diego Project’s potential was confirmed by SGS Canada’s view that the 43-101 silver resources could potentially be expanded based on existing structures, as well as lateral and depth extensions – Managements four key high priority targets include the 1849, Fernandez, Trovador, and Arroyo Zones. The San Diego project is fully permitted for drilling.  A drill program is being designed to...

Continue reading

R1 RCM to Release Second Quarter 2020 Results on August 4

CHICAGO, July 21, 2020 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2020 before market open on Tuesday, August 4, 2020.R1’s management team will host a conference call on August 4 at 7:00 a.m. CT (8:00 a.m. ET) to discuss the results and business outlook. To participate, please dial 833-968-2190 (778-560-2796 outside the U.S. and Canada), using conference code number 5343659. A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at r1rcm.com.About R1 RCMR1 RCM is a leading provider of technology-enabled RCM services which transform and solve revenue cycle performance challenges...

Continue reading

Swiss Water Announces Appointment of New Director and Interim Chair

VANCOUVER, British Columbia, July 21, 2020 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX – SWP) (“Swiss Water” or “the company”) today announced that Donald Tringali was elected to the Board of Directors of the company, effective July 20, 2020.Don Tringali is the founder and Chief Executive Officer of Augusta Advisory Group, a US-based boutique financial and business consulting firm providing a full range of executive, operations and corporate advisory services to leading public and private companies in a wide array of industries. He brings over 30 years of experience as a business lawyer, C-level executive, independent corporate director and board advisor to his new role. Mr. Tringali holds a BA in Economics from UCLA and a JD (Juris Doctor) degree from Harvard Law School.Swiss Water also announced that Diane Fulton...

Continue reading

Alector to Present Data from the AL001 Phase 2 Open-Label Study in Frontotemporal Dementia at the 2020 Alzheimer’s Association International Conference

SOUTH SAN FRANCISCO, Calif., July 21, 2020 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the company will highlight preliminary data from a Phase 2 open-label study evaluating AL001 in individuals with frontotemporal dementia at the upcoming 2020 Alzheimer’s Association International Conference being held virtually, July 27-31, 2020.Details for the oral presentation:Presentation Title: AL001 Restores CSF PGRN Levels and Normalizes Disease-associated Biomarkers in Individuals with Frontotemporal Dementia due to Heterozygous Mutations in the Progranulin GeneSession Name: Human: Putative Therapeutic Results for Alzheimer’s and Related DementiasPresenter: Robert Paul, M.D., Ph.D., Chief Medical Officer, AlectorDate: Presentation will be available...

Continue reading

Stop & Shop Reaches Tentative Withdrawal Agreement with Local Unions on UFCW International Union – Industry Pension Fund

Zaandam, the Netherlands, July 21, 2020 – Ahold Delhaize announces today that its U.S. brand Stop & Shop, reached a tentative agreement to terminate its participation in the United Food & Commercial Workers International Union (UFCW) – Industry Pension Fund (the “National Plan”), through a transaction that the National Plan’s trustees determined to be in the best interests of the National Plan’s participants and beneficiaries. While the plan is not in critical status, the tentative agreement does importantly improve the security of pension benefits for associates as well as reduces financial risk for the company. If ratified by the UFCW Locals, the transaction will be treated as an extraordinary item and will therefore not impact the underlying operating results outlook for 2020. This statement should not be interpreted as an...

Continue reading

SmartFinancial Announces Results for the Second Quarter 2020

KNOXVILLE, Tenn., July 21, 2020 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial” or the “Company”; NASDAQ: SMBK), today announced net income of $6.2 million, or $0.41 per diluted common share, for the second quarter of 2020, compared to net income of $2.7 million, or $0.19 per diluted common share for the first quarter of 2020.  Operating earnings (Non-GAAP), which excludes securities gains, merger related and restructuring expenses and non-operating items, totaled $7.3 million, or $0.48 per diluted common share, in the second quarter of 2020, compared to $4.3 million, or $0.30 per diluted common share, in the first quarter of 2020.Highlights for the Second Quarter of 2020

Continue reading

Emergent BioSolutions Inc. to be Added to the S&P MidCap 400 Index

GAITHERSBURG, Md., July 21, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that Standard & Poor’s (S&P) has indicated that the company will be added to the S&P MidCap 400® index, effective prior to the open of trading on Friday, July 24. The company will be classified under S&P’s Global Industry Classification Standard (GICS) Biotechnology Sub-Industry index.“The addition of Emergent to the S&P MidCap 400 is an important milestone as we continue on our growth trajectory,” said Richard S. Lindahl, executive vice president and chief financial officer of Emergent BioSolutions. “This move reflects our strong progress as a global life sciences company committed to addressing public health threats, and our efforts to maximize shareholder value by growing revenues and prudently reinvesting...

Continue reading

Tonix Pharmaceuticals Holding Corp. Announces Rescheduling of Special Meeting of Stockholders

NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it is rescheduling the date of the Company’s Special Meeting of Stockholders (the “Special Meeting”) previously scheduled for Friday, June 26, 2020, to Friday, August 28, 2020, at 11:00 a.m., Eastern Time. In connection with the change of the Special Meeting date, the record date for determining stockholders entitled to attend and vote at the Special Meeting has been changed to the close of business on July 15, 2020. There are no changes to the proposals previously described in the Company’s proxy statement for the Special Meeting. The Company will be distributing a proxy statement, proxy card and notice of internet availability for the Special Meeting...

Continue reading

DraftKings to Release Second Quarter 2020 Results August 14

BOSTON, July 21, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (the “Company”, “DraftKings”) today announced that it will release its second quarter 2020 results prior to 8:30AM EDT on August 14, 2020.At 8:30AM EDT on the same day, DraftKings will host a conference call to discuss the results.The Company’s earnings press release and related materials will be available at investors.draftkings.com. To listen to the audio webcast and live Q&A, please visit DraftKings’ investor relations website at investors.draftkings.com. The audio webcast and accompanying presentation will be available on the Company’s investor relations website until 11:59PM EDT on September 14, 2020. About DraftKingsDraftKings Inc. (Nasdaq: DKNG) is a digital sports entertainment and gaming company created to fuel the competitive spirits of sports...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.